Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berti

Showing results (191-200 of 218) with videos related to

Pageof 22
Sort By:
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|December 22, 2015
Patient kinesiophobia affects both recovery time and final outcome after total knee arthroplastyG Filardo, A Roffi, G Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II studyA A Brandes, M Ermani, S Turazzi, et al.
Scientific Reports|June 30, 2023
A universal UHPLC-CAD platform for the quantification of polysaccharide antigensA Corrado, M De Martino, V Bordoni, et al.
Journal of Neuro-Oncology|December 1, 1996
Early chemotherapy and concurrent radio-chemotherapy in high grade gliomaA A Brandes, A Rigon, P Zampieri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective studyA A Brandes, E Scelzi, G Salmistraro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II studyA A Brandes, M Ermani, U Basso, et al.
Vaccine|February 5, 2016
Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccinesS Pecetta, B Vijayakrishnan, M R Romano, et al.
Vaccine|June 19, 2016
Preclinical studies on new proteins as carrier for glycoconjugate vaccinesM Tontini, M R Romano, D Proietti, et al.
Arzneimittel-Forschung|January 1, 1987
Interference of the new antiinflammatory compound flunoxaprofen with eicosanoid formation in various biological systemsF Berti, G Galli, C Omini, et al.
Vaccine|December 1, 2010
Vi-CRM 197 as a new conjugate vaccine against Salmonella TyphiF Micoli, S Rondini, I Pisoni, et al.
Pageof 22

Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|December 22, 2015
Patient kinesiophobia affects both recovery time and final outcome after total knee arthroplastyG Filardo, A Roffi, G Merli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II studyA A Brandes, M Ermani, S Turazzi, et al.
Scientific Reports|June 30, 2023
A universal UHPLC-CAD platform for the quantification of polysaccharide antigensA Corrado, M De Martino, V Bordoni, et al.
Journal of Neuro-Oncology|December 1, 1996
Early chemotherapy and concurrent radio-chemotherapy in high grade gliomaA A Brandes, A Rigon, P Zampieri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective studyA A Brandes, E Scelzi, G Salmistraro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II studyA A Brandes, M Ermani, U Basso, et al.
Vaccine|February 5, 2016
Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccinesS Pecetta, B Vijayakrishnan, M R Romano, et al.
Vaccine|June 19, 2016
Preclinical studies on new proteins as carrier for glycoconjugate vaccinesM Tontini, M R Romano, D Proietti, et al.
Arzneimittel-Forschung|January 1, 1987
Interference of the new antiinflammatory compound flunoxaprofen with eicosanoid formation in various biological systemsF Berti, G Galli, C Omini, et al.
Vaccine|December 1, 2010
Vi-CRM 197 as a new conjugate vaccine against Salmonella TyphiF Micoli, S Rondini, I Pisoni, et al.
Pageof 22